I would like to applaud a 2019 article by Mitsuru Ito and colleagues from the Center for Excellence in Thyroid Care at Kuma Hospital, Kobe, Japan. Dear researchers, your article, “Thyroid function related symptoms during monotherapy in athyreotic patients” showcased… Read More ›
A clinical trial comparing Armour Thyroid (NDT) and Levothyroxine (LT4) is now recruiting patients in the United States. The sponsor of the study is Allergan, the makers of Armour Thyroid in the United States. They hope to recruit 220 patients… Read More ›
This final section of my paraphrase of Hoermann et al’s landmark 2016 article articulates the shift from the limited, older TSH-T4 paradigm to the new paradigm that includes T3 hormone. Interrelational Measures and Emerging New Concepts of Thyroid Homeostasis [Paraphrase… Read More ›
Why are some people extremely hypothyroid while their TSH is above reference range, while others have no symptoms and are completely healthy? How important is the Free T3 test when diagnosing true “euthyroid” status within the TSH reference range? Is… Read More ›
Does the statistically-defined “normal” TSH reference range for the healthy population describe the TSH range for a healthy individual? Does having a TSH within the normal laboratory range always mean you, as an individual are biologically euthyroid? Does falling outside… Read More ›
In a series of posts, I’m sharing my plainer-English paraphrase of a very important article in thyroid science. My hope is that the public, doctors, and educated thyroid patients can better understand and appreciate its insights. This article by Dr…. Read More ›
Canadians can take pride in their historical defense of T3 testing in thyroid therapy. Our job defending the T3 test today is to remind people of what has changed since then in thyroid testing, and what is still the same…. Read More ›
There’s no surprise that patients and doctors would disagree about the incidence rate of hypothyroid symptoms in a given patient. “We have an average of 7.2 symptoms per patient” says the cohort of 262 patients. “No, you have an average… Read More ›